Concurrent Tissue Engineering for Wound Healing in Diabetic Rats Utilizing Dual Actions of Green Synthesized CuO NPs Prepared from Two Plants Grown in Egypt
DOI: https://doi.org/10.2147/IJN.S397045
IF: 7.033
2023-04-11
International Journal of Nanomedicine
Abstract:Noha Khalifa Abo Aasy, 1 Sarah A El-Lakany, 1 Perusi M Masanga, 2 Elbadawy A Kamoun, 3, 4 Shahira H EL-Moslamy, 5 Marwa Abu-Serie, 6 Rania G Aly, 7 Nazik A Elgindy 1 1 Department of Industrial Pharmacy, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt; 2 St John's University of Tanzania, Dodoma, Tanzania; 3 Polymeric Materials Research Department, Advanced Technology and New Materials Research Institute (ATNMRI), City of Scientific Research and Technological Applications (SRTA-City), New Borg El-Arab City, Egypt; 4 Nanotechnology Research Center (NTRC), The British University in Egypt (BUE), El-Sherouk City, Cairo, 11837, Egypt; 5 Bioprocess Development Department (BID), Genetic Engineering and Biotechnology Research Institute (GEBRI), City of Scientific Research and Technological Applications (SRTA-City), New Borg El-Arab City, Alexandria, 21934, Egypt; 6 Medical Biotechnology Department (MBD), Genetic Engineering and Biotechnology Research Institute (GEBRI), City of Scientific Research and Technological Applications (SRTA-city), New Borg El-Arab City, Alexandria, 21934, Egypt; 7 Department of Surgical Pathology, Faculty of Medicine, Alexandria University, Alexandria, Egypt Correspondence: Sarah A El-Lakany, Department of Industrial Pharmacy Faculty of Pharmacy, Alexandria University, 1 El Khartoum Square, PO Box 21521, Alexandria, Egypt, Tel +201002828663, Fax +203 4871668, Email ; Purpose: Diabetes mellitus is among the disrupting factors of orchestrated events in wound healing. This necessitates the urge for tailored medications, which are continually offered by nano-sized materials. Herein, we present greenly synthesized copper oxide nanoparticles (CuO NPs), obtained from either Punica granatum L . (PG) or Pisidium guajava L . (GV) extract, to function as potent bactericidal and fungicidal materials that promote regeneration and healing of the targeted diabetic wounded tissues. Methods: PG or GV plant extracts were compared as source of reducing agents for CuO NPs synthesis process. The yield and photocatalytic degradation potential were compared. NPs obtained from the superior extract, PG, were characterized using particles size, zeta potential, XRD, TEM, SEM, and EDX. The antimicrobial effects were evaluated on multidrug-resistant human pathogens and then the percentage biofilm inhibitory concentration was determined. The cytotoxicity and wound scratch study were conducted on a normal human skin cell line. In-vivo wound healing activity in diabetic rats was assessed along with histopathological and immunohistochemical examination of CD45 and α-SMA. Results: The greenly synthesized CuO NPs are spherical in shape having a diameter of 233nm. CuO NPs (250μg/mL) acted as promising biocontrol agent against a variety of multidrug-resistant human pathogens. They significantly exhibited 29.460± 0.811% healing of the scratched wound compared to only 2.001± 0.155% for the control. Wound healing experiments revealed the safety of a low CuO NPs concentration in a diabetic animal model as well as on human normal skin fibroblast cell line. The treated group with a dose of 2mg/cm 2 showed superior results with a WC50 value of 7.2 days, and 92% wound contraction after 13-days. Immunohistochemical investigation of the same group demonstrated well-established fibrous tissue (5.7± 3.7/HPF), and an amplified granulation tissue of recently developed blood vessels (70± 1.5/HPF). Conclusion: Green synthesized CuO NPs could overcome drug resistance and promote wound healing process effectively. Keywords: plant extraction, metal ion, cell compatibility, wound contraction, biofilm inhibitory concentration The optimal skin wound healing process involves an established coordination between both biological and molecular events, within a proper time frame, during the well-known healing stages, namely inflammatory, proliferative, and remodeling. Unfortunately, the disruption of such orchestrated events results in an impaired healing process. One major cause is Diabetes mellitus, where diabetic patients are more vulnerable to delayed healing with the accompanying health complications. In fact, diabetes mellitus is a metabolic disorder that may result in severe neurodegeneration, where diabetics suffer from low nitric oxide levels. Nitric oxide is a key moiety that can interact with many intracellular targets to trigger an array of signal transduction pathways, resulting in stimulatory or inhibitory output signals. 1–3 Although xenografts, allografts, and autografts are the biomedical approaches of choice, their employment is highly retarded -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology